The MUB40 Peptide for Use in Detecting Neutrophil-Mediated Inflammation Events
January 7th, 2019
5.7K views
Here, we present a protocol to detect the presence of neutrophils in fixed/permeabilized histology sections and assess the activation state of live purified neutrophils. In particular, the MUB40 peptide binds lactoferrin present in neutrophil-specific and tertiary granules. Exposure of the granule contents through either permeabilization or neutrophil activation allows for the marking of neutrophils.
Overview
This study presents a protocol for detecting neutrophils in tissue samples and evaluating their activation state using the MUB40 peptide, which binds lactoferrin found in neutrophil granules. The method effectively allows for specific labeling of neutrophils in both live and fixed samples, providing insights into their role in inflammation.
Key Study Components
Research Area
- Inflammatory diseases
- Neutrophil activation and recruitment
- Immunohistochemistry
Background
- MUB40 serves as a novel marker for neutrophils.
- The technique aims to aid diagnosis in inflammatory conditions.
- Neutrophils are key players in the immune response.
Methods Used
- Isolation of neutrophils from human blood samples
- Use of MUB40 for specific detection in live and fixed tissues
- Imaging techniques for visualizing neutrophil activity
Main Results
- MUB40 successfully labeled neutrophils in both live and fixed samples.
- Real-time visualization of neutrophil granule secretion dynamics.
- Technique applicable to various tissue types and conditions.
Conclusions
- The study demonstrates a reliable method for neutrophil detection and analysis.
- This protocol can enhance understanding of neutrophils in inflammatory responses, aiding future research.
Frequently Asked Questions
What is the significance of MUB40 in studying neutrophils?
MUB40 allows for specific detection and visualization of neutrophils, contributing to research in inflammation.
Can MUB40 be used on fixed tissues?
Yes, MUB40 can be used to label neutrophils in both live and fixed tissues.
How does MUB40 improve neutrophil labeling?
It provides an easy and specific method for identifying neutrophils across various tissues.
What types of samples can this protocol be applied to?
The protocol is applicable to human and mammalian tissue samples, as well as patient and animal model inflamed tissues.
What is one of the main applications of using MUB40?
MUB40 can be used to explore neutrophilic recruitment and activation in inflammatory diseases.
Is the method time-consuming?
The protocol is designed to be quick and efficient for labeling neutrophils.
Are there variations of MUB40 for extended use?
Yes, several MUB40 derivatives have been developed to widen its application in research.
Executive Industry Relevance
The MUB40 peptide enables robust detection of neutrophil-mediated inflammation across diverse mammalian models, addressing a key bottleneck in translational immunology and inflammation research. Its species-agnostic binding and compatibility with both live and fixed samples streamline comparative studies and reduce reagent redundancy, supporting predictive confidence in early discovery and preclinical workflows. This capability enhances portfolio-wide assay harmonization and accelerates mechanistic de-risking for inflammation-targeted programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct visualization of neutrophil activation and degranulation in disease-relevant systems.
- Supports functional target validation by quantifying neutrophil responses to candidate modulators.
- Facilitates mechanistic de-risking by distinguishing activated from resting neutrophil populations.
- Improves predictive confidence for inflammation-related target selection.
Screening & Assay Development
- Provides a standardized, single-step staining protocol for high-content imaging assays.
- Reduces assay variability by eliminating species-specific antibody dependencies.
- Enables reproducible quantification of neutrophil activation across multiple models.
- Streamlines assay development for compound screening targeting neutrophil function.
Translational & Preclinical Research
- Aligns neutrophil detection across human and animal tissues for translational biomarker studies.
- Supports continuity from in vitro discovery to in vivo preclinical validation of inflammation mechanisms.
- Enables risk-adjusted advancement decisions by providing consistent readouts in diverse models.
- Facilitates cross-study comparisons and meta-analyses in inflammation research portfolios.
Pipeline & Workflow Integration
MUB40-based detection integrates from early discovery through preclinical validation, supporting workflows from hypothesis testing to lead identification in inflammation and immunology programs.
- Discovery Biology: Provides quantitative readouts of neutrophil activation for hypothesis-driven studies.
- Screening: Delivers assay-ready, reproducible staining for high-throughput and high-content platforms.
- Analytics: Enables direct measurement of degranulation and activation events for comparative analysis.
- Translational Research: Bridges human and animal model data for biomarker alignment and validation.
- Enterprise Reuse: Offers a broadly applicable detection tool, reducing the need for multiple species-specific reagents.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in inflammation research.
- Operational Value: Standardizes neutrophil detection, improving reproducibility and scalability across studies.
- Strategic Value: Accelerates go/no-go decisions and enhances capital efficiency in inflammation-focused portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization and cross-program data integration.
Implementation Considerations
- Requires expertise in immunofluorescence and live-cell imaging for optimal deployment.
- Needs access to fluorescence microscopy and compatible analytical infrastructure.
- Demands cross-team standardization for protocol harmonization in multi-site studies.
- Adaptable to various mammalian models and tissue types, supporting broad translational use.
- Limited to detection of activated or permeabilized neutrophils due to membrane exclusion properties.
Biopharma FAQs
Why is null hypothesis testing critical for MUB40-based neutrophil detection?
Null hypothesis testing ensures that observed MUB40 staining reflects true neutrophil activation rather than background or non-specific binding, supporting rigorous target validation and reducing false positives in inflammation studies.
How does independent variable isolation enhance neutrophil activation assays using MUB40?
Isolating variables such as stimulant concentration or incubation time allows precise attribution of MUB40 signal changes to specific experimental conditions, strengthening mechanistic insights and discovery-stage decision making.
What do quantitative dependent variable measurements enable in MUB40 imaging workflows?
Quantitative measurement of fluorescence intensity or cell counts enables objective comparison of neutrophil activation across samples, facilitating robust screening and translational biomarker development.
Why are replication requirements important for cross-functional teams using MUB40 protocols?
Replication ensures that MUB40-based neutrophil detection is reproducible across operators and sites, supporting reliable data integration and collaborative assay development in multi-team R&D environments.
What statistical analysis capabilities are needed before implementing MUB40-based neutrophil assays?
Teams require statistical tools to assess signal-to-noise ratios, inter-sample variability, and significance of activation readouts, ensuring that MUB40 assay outputs meet enterprise standards for decision making.
